Maiwall R, Kulkarni AV, Arab JP, Piano S. Acute liver failure. Lancet. 2024;404:789–802.

Google Scholar 

Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6:542–53.

Google Scholar 

Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev. 2021;176: 113869.

Google Scholar 

Zhang D-Y, Tu T, Younis MR, Zhu KS, Liu H, Lei S, et al. Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury. Theranostics. 2021;11:9904–17.

Google Scholar 

Liu Y, Lou G, Li A, Zhang T, Qi J, Ye D, et al. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages. EBioMedicine. 2018;36:140–50.

Google Scholar 

Tiegs G, Horst AK. TNF in the liver: targeting a central player in inflammation. Semin Immunopathol. 2022;44:445–59.

Google Scholar 

Tu H, Xiong W, Zhang J, Zhao X, Lin X. Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation. Nat Commun. 2022;13:6603.

Google Scholar 

Zhang N, Liu J, Guo R, Yan L, Yang Y, Shi C, et al. Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Mol Cell. 2024;84:4419-4435.e10.

Google Scholar 

Weinlich R, Green DR. The two faces of receptor interacting protein kinase-1. Mol Cell. 2014;56:469–80.

Google Scholar 

Zhang X, Dowling JP, Zhang J. RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development. Cell Death Dis. 2019;10:245.

Google Scholar 

Li W, Yuan J. Targeting RIPK1 kinase for modulating inflammation in human diseases. Front Immunol. 2023;14: 1159743.

Google Scholar 

Tao L, Yi Y, Chen Y, Zhang H, Orning P, Lien E, et al. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages. Cell Death Differ. 2021;28:1418–33.

Google Scholar 

Lou G, Li A, Cen Y, Yang Q, Zhang T, Qi J, et al. Selonsertib, a potential drug for liver failure therapy by rescuing the mitochondrial dysfunction of macrophage via ASK1–JNK–DRP1 pathway. Cell Biosci. 2021;11: 9.

Google Scholar 

Cao L, Mu W. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacol Res. 2021;163: 105297.

Google Scholar 

Christofferson DE, Li Y, Yuan J. Control of Life-or-Death Decisions by RIP1 Kinase. Annu Rev Physiol. 2014;76:129–50.

Google Scholar 

Hu Y, Zhang H, Xie N, Liu D, Jiang Y, Liu Z, et al. Bcl-3 promotes TNF-induced hepatocyte apoptosis by regulating the deubiquitination of RIP1. Cell Death Differ. 2022;29:1176–86.

Google Scholar 

Gordon ER, Jones ME, Adler BL. Acute liver failure and a rash. Gastroenterology. 2025. https://doi.org/10.1053/j.gastro.2025.01.225.

Article  Google Scholar 

European Association for the Study of the Liver. EASL clinical practice guidelines on acute-on-chronic liver failure. J Hepatol. 2023;79:461–91.

Google Scholar 

Deng B, Ma Y, Huang J, He R, Luo M, Mao L, et al. Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes. Sci Adv. 2024;10: eado1550.

Google Scholar 

Huang Z, Zheng D, Pu J, Dai J, Zhang Y, Zhang W, et al. Microrna-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway. Biosci Biotechnol Biochem. 2019;83:829–35.

Google Scholar 

Wu T-X, Pang H-Z, Liu X-D, Liu L, Tang Y-F, Luo X-F, et al. Adiponectin alleviates inflammatory response in metabolic dysfunction-associated steatohepatitis by inhibiting NLRP3 inflammasome-mediated hepatocyte pyroptosis. Hepatobiliary Pancreat Dis Int. 2025. https://doi.org/10.1016/j.hbpd.2025.04.004.

Article  Google Scholar 

Kolodziejczyk AA, Federici S, Zmora N, Mohapatra G, Dori-Bachash M, Hornstein S, et al. Acute liver failure is regulated by MYC- and microbiome-dependent programs. Nat Med. 2020;26:1899–911.

Google Scholar 

Huang W, Jiang L, Jiang Y, Li S, Liu W, Zong K, et al. ANGPTL4 induces Kupffer cell M2 polarization to mitigate acute rejection in liver transplantation. Sci Rep. 2025. https://doi.org/10.1038/s41598-024-81832-x.

Article  Google Scholar 

Huang Z, Mou T, Luo Y, Pu X, Pu J, Wan L, et al. Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB. Cell Death Dis. 2020. https://doi.org/10.1038/s41419-020-2648-0.

Article  Google Scholar 

Wu P-P, Shen X-J, Zheng S-S. Cisplatin induces acute liver injury by triggering caspase-3/GSDME-mediated cell pyroptosis. Hepatobiliary Pancreat Dis Int. 2025;24:177–87.

Google Scholar 

Li T-T, Luo Y-H, Yang H, Chai H, Lei Z-L, Peng D-D, et al. FBXW5 aggravates hepatic ischemia/reperfusion injury via promoting phosphorylation of ASK1 in a TRAF6-dependent manner. Int Immunopharmacol. 2021;99: 107928.

Google Scholar 

Cao K, Zhu J, Lu M, Zhang J, Yang Y, Ling X, et al. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma. EBioMedicine. 2024;99: 104920.

Google Scholar 

Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev. 2010;90:1165–94.

Google Scholar 

Moyer A, Tanaka K, Cheng EH. Apoptosis in cancer biology and therapy. Annu Rev Pathol Mech Dis. 2025;20:303–28.

Google Scholar 

Wei H, Yi K, Li F, Li D, Yang J, Shi R, et al. Multimodal tetrahedral DNA nanoplatform for surprisingly rapid and significant treatment of acute liver failure. Adv Mat. 2024;36:2305826.

Google Scholar 

Dara L, Johnson H, Suda J, Win S, Gaarde W, Han D, et al. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology. 2015;62:1847–57.

Google Scholar 

Chen D, Ni H-M, Wang L, Ma X, Yu J, Ding W-X, et al. P53 up-regulated modulator of apoptosis induction mediates acetaminophen-induced necrosis and liver injury in mice. Hepatology. 2019;69:2164–79.

Google Scholar 

Iorga A, Donovan K, Shojaie L, Johnson H, Kwok J, Suda J, et al. Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity. J Biol Chem. 2021;296: 100300.

Google Scholar 

Clucas J, Meier P. Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death. Nat Rev Mol Cell Biol. 2023;24:835–52.

Google Scholar 

Sheen-Chen S-M, Ho H-T, Chen W-J, Eng H-L. Effect of ZVAD-fmk on hepatocyte apoptosis after bile duct ligation in rat. World J Gastroenterol. 2005;11:2330–3.

Google Scholar 

Berger SB, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M, et al. Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol. 2014;192:5476–80.

Google Scholar 

Kondylis V, Pasparakis M. RIP kinases in liver cell death, inflammation and cancer. Trends Mol Med. 2019;25:47–63.

Google Scholar